These phages, bacteriophages, are amazing. Basically, in ultra, ultra drug-resistant infections, you can use a targeted virus that will kill that specific bacteria. That technology exists. It's used infrequently throughout the world. We have that technology in Canada.
One issue is that it's tough to regulate. It's not a mass-produced product that has all the regulatory bodies. If we want to use it, we have to go through a very appropriate and timely process to ensure that, for that specific instance, it's approved.
Anti-microbial resistance is not going away. This is going to get a lot worse before it gets better. It is not a matter of Canada doing the right thing; it's the world doing the right thing. We can get ahead of this. We can start to figure out how to use phage therapy more effectively and more rapidly.
This would be one of many important areas to study. We're looking at science and research, and this is one important pillar that often gets ignored.